Search Results 1971-1980 of 13397 for monoclonal antibody

1. Myeloma Referral Study (Race, Ethnicity, and Familial Etiologic Relationship, Risk Association, and Linkage Study) - Mayo Clinic

   About this study. The goal of the present study is to answer the question of whether there are clinically relevant subtypes of monoclonal gammopathy of ...

2. Multiple myeloma - Doctors and departments - Mayo Clinic

   Amyloidosis, Multiple myeloma, Monoclonal gammopathy of undetermined significance ... Bispecific antibody therapy · Bone marrow transplant · Cancer treatment ...

3. Study to Evaluate Serial Amnioinfusions as Therapy for Pulmonary Hypoplasia in Fetuses with Renal Failure or Severe Renal Anomalies - Mayo Clinic

   ... antibody and an alkylating agent. DLBCL cohort: patients with DLBCL that has relapsed after or is refractory to at least 2 prior lines of systemic therapy ...

4. Cabozantinib And Nivolumab In Treating Patients With Advanced, Recurrent Or Metastatic Endometrial Cancer - Mayo Clinic

   ... antibodies) or radiotherapy within 4 weeks ... Patients should be excluded if they have had prior treatment with anti-CTLA-4 antibody or any other antibody ...

5. Risk Factors Associated with Clustered Plasma Cell Dyscrasias in Minnesota - Mayo Clinic

   Confirmed diagnosis of multiple myeloma (MM), Waldenstrom macroglobulinemia (WM) or monoclonal gammopathy of undetermined significance (MGUS); Agreement in ...

6. Open-label Study Of The Safety And Activity Of Oprozomib In Patients With Hematologic Malignancies - Mayo Clinic

   ... antibody therapy. Radiation therapy within 3 weeks prior to first dose. Radioimmunotherapy within 8 weeks prior to first dose. Localized radiation therapy ...

7. Study Of Pomalidomide And Low Dose Dexamethasone With Or Without Pembrolizumab (MK-3475) In Refractory Or Relapsed And Refractory Multiple Myeloma (RrMM) (MK-3475-183/KEYNOTE-183) - Mayo Clinic

   ... antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell costimulation or checkpoint pathways); Is pregnant or breast ...

8. Multiple myeloma - Doctors and departments - Mayo Clinic

   Bispecific antibody therapy · Bone marrow transplant · Cancer treatment · CAR-T cell therapy · Chemotherapy · Complete blood count (CBC) · Creatinine test · CT ...

9. Hematology - Clinical trials

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

10. Cabozantinib-S-Malate In Treating Younger Patients With Recurrent, Refractory, Or Newly Diagnosed Sarcomas, Wilms Tumor, Or Other Rare Tumors - Mayo Clinic

    Antibodies: ≥ 21 days must have elapsed from infusion of last dose of antibody, and toxicity related to prior antibody therapy must be recovered to Grade ≤ 1.